Clinical Trial Update: Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes

View source ↗

Summary

An observational study, sponsored by AstraZeneca, assesses real-world use of exenatide with basal insulin in patients with type 2 diabetes; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Basal insulin (basal insulin)
• EXENATIDE (EXENATIDE)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2014-01-16